News
In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...
Bitcoin Depot Inc. BTM shares have skyrocketed 250.6% this year, significantly outperforming the industry, the Zacks Finance ...
In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an immunotherapy drug) plus gemcitabine and cisplatin (GemCis, chemotherapy drugs) as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results